XCUR vs XNCR

Exicure, Inc. vs Xencor, Inc. — Valuation Comparison 2026

XCUR

Biotechnology
Exicure, Inc.
Quality
4.3
out of 10
Value Trap
60
DANGER
Price
$2.97
Last close
Models
9/13
Active
VS

XNCR

Biotechnology
Xencor, Inc.
Quality
6.1
out of 10
Value Trap
15
SAFE
Price
$11.97
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType XCUR Fair ValueXCUR Upside XNCR Fair ValueXNCR Upside
Bayesian DCF Intrinsic $1.16 -60.8% $1.41 -88.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.93 -68.8% $0.99 -91.2%
Dynamic NAV Asset-Based $0.08 -97.2% $5.40 -54.9%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for XCUR vs XNCR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

XCUR vs XNCR — Which Stock Is More Undervalued?

XNCR scores higher with a 6.1/10 quality rating vs XCUR's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Exicure, Inc. (XCUR) and Xencor, Inc. (XNCR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

XCUR currently trades at $2.97 with a QOC of 4.3/10, while XNCR trades at $11.97 with a QOC of 6.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).